Ricky Newton, CPA
Advertisement
Articles by Ricky Newton, CPA
The advent of oral oncolytics has changed the pharmacy's role in patient care beyond compounding infusions. Pharmacy staff now routinely engage patients, assessing adherence and tolerance to therapy as well as helping them navigate prescription benefits.
Advertisement
Latest Updated Articles
- PBMs: Their Role, the Problems, and How Practices Can Work With Them
October 17th 2017
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Lutetium Lu 177 for Earlier-Stage Prostate Cancer
2
FDA Panel Backs 6 Peptides for Compounding
3
Atacicept Becomes First BAFF/APRIL Inhibitor Approved for IgA Nephropathy: Richard Lafayette, MD
4
Expanding Community Access to CAR T, Bispecific Therapies in Multiple Myeloma: Peter Forsberg, MD
5